Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Income Statement

Financials in millions AUD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Revenue	0.08	0.07	0.06	0.1	12.2
Revenue Growth (YoY)	2.74%	23.73%	-42.16%	-99.16%	291.99%
Gross Profit	0.08	0.07	0.06	0.1	12.2
Selling, General & Admin	6.38	6.65	6.51	5.57	4.61
Research & Development	12.77	11.27	7.02	3	4.57
Other Operating Expenses	0	0.01	0.12	-0.19	0.44
Operating Expenses	19.16	17.93	13.66	8.38	9.62
Operating Income	-19.08	-17.85	-13.6	-8.28	2.58
Interest Expense / Income	0.03	0.03	0.01	-0.06	0
Other Expense / Income	0.45	0.32	0.28	0.06	-0.03
Pretax Income	-19.56	-18.21	-13.88	-8.27	2.61
Net Income	-19.56	-18.21	-13.88	-8.27	2.61
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change	188.30%	90.24%	320.63%	19.19%	-16.47%
EPS (Basic)	-0.14	-0.38	-0.55	-1.38	0.52
EPS (Diluted)	-0.14	-0.38	-0.55	-1.38	0.52
Free Cash Flow	-18.01	-15.91	-13.05	-7.63	4.39
Free Cash Flow Per Share	-13.00	-33.10	-51.66	-127.00	87.11
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-25441.33%	-24457.53%	-23044.07%	-8118.63%	21.17%
Profit Margin	-26082.67%	-24942.47%	-23528.81%	-8111.76%	21.39%
Free Cash Flow Margin	-24017.33%	-21797.26%	-22123.73%	-7479.41%	35.99%
EBITDA	-19.15	-17.78	-13.45	-7.96	2.77
EBITDA Margin	-25530.67%	-24361.64%	-22800.00%	-7805.88%	22.68%
Depreciation & Amortization	0.38	0.39	0.42	0.37	0.16
EBIT	-19.53	-18.18	-13.88	-8.34	2.61
EBIT Margin	-26038.67%	-24898.63%	-23518.64%	-8172.55%	21.39%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).